宫颈癌图像引导近距离放疗后失败模式的变化:RetroEMBRACE研究分析
分析RetroEMBRACE队列中12家机构731例接受放化疗联合MRI或CT图像引导自适应近距离放疗(IGABT)的宫颈癌患者失败模式。325次失败中局部占9%、区域占6%、盆腔占13%、腹主动脉旁淋巴结(PAN)占9%、全身占21%、远处(全身+PAN)占24%。作者结论:IGABT后以全身失败为主,而传统近距离放疗以盆腔失败为主。
要点
- 731例中222例(30%)出现失败,共325次单发或同步失败。
- 失败部位:局部9%、区域6%、盆腔13%、PAN 9%、全身21%、远处24%。
- 40%至50%的失败发生在第1年,另20%至30%发生在第2年。
核心结论
- IGABT的实施改变了宫颈癌放化疗后的复发模式,IGABT后以全身失败为主,而传统近距离放疗以盆腔失败为主。
- 作者认为除IGABT和放化疗外,需要有效治疗以清除PAN和远处器官的微转移,从而最大化局部、区域、PAN和全身控制并改善生存。
研究设计与样本
- 回顾性分析RetroEMBRACE队列中12家机构731例接受放化疗联合基于磁共振成像或计算机断层扫描的IGABT的宫颈癌患者。
- 分析首次复发时的失败模式。
主要发现
- 731例中222例(30%)出现325次单发或同步失败。
- 325次失败中局部占9%、区域占6%、盆腔(局部或区域)占13%、腹主动脉旁淋巴结(PAN)占9%、全身占21%、远处(全身+PAN)占24%。
- 222例治疗失败患者中,21%仅盆腔失败、57%仅远处失败、23%同时存在盆腔和远处失败。
- 全部失败中40%至50%发生在第1年,另20%至30%发生在第2年。
- 局部、区域和PAN失败在3年后趋于平台,而全身失败持续发生至第10年。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Image guided adaptive brachytherapy (IGABT) for cervical cancer improves pelvic control and survival across all stages. Improvement in pelvic control is larger in advanced stages, but improvement in survival is similar across stages. This paper analyzes the patterns of failure in the RetroEMBRACE cohort to investigate this discrepancy. METHODS AND MATERIALS: 731 patients from 12 institutions treated with chemoradiation therapy and magnetic resonance imaging or computed tomography-based IGABT were evaluated. The pattern of failure at time of first relapse was analyzed. RESULTS: Three hundred twenty-five failures (single and synchronous) occurred in 222 of 731 patients (30%). Among the 325 failures, 9% were local and 6% regional. Pelvic (local or regional) failures made up 13%, paraaortic node (PAN) 9%, systemic 21%, and distant (systemic + PAN) 24%. Of the 222 patients with treatment failure, 21% had pelvic failure alone, 57% had distant failure alone, and 23% had both pelvic and distant failure. Of all failures that occurred, 40% to 50% occurred in the first year, with a further 20% to 30% occurring in the second year. Although local, regional, and PAN failure tended to plateau after year 3, systemic failure continued to occur up to year 10. CONCLUSIONS: Implementation of IGABT has changed the patterns of relapse after chemoradiation therapy for cervical cancer. The predominant failure after IGABT is systemic, whereas the predominant failure with conventional brachytherapy is pelvic. Effective treatments to eradicate micrometastases in PAN and distant organs are needed in addition to IGABT and chemoradiation therapy to maximize local, regional, PAN, and systemic control and improve survival.
引用
- Tan LT, Pötter R, Sturdza A, et al. Change in Patterns of Failure After Image-Guided Brachytherapy for Cervical Cancer: Analysis From the RetroEMBRACE Study. Int J Radiat Oncol Biol Phys. 2019. PMID: 30940530. doi:10.1016/j.ijrobp.2019.03.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。